Skip to main content
Home
language-selector-globe Sandoz | en
Choose Location
  • Americas
  • Asia Pacific
  • Europe
  • International
  • Middle East & Africa
Argentina | es
Brazil | pt
Canada | en
Canada | fr
Mexico | es
United States | en
Australia | en
Japan | ja
Korea | ko
Mainland China | zh
Austria | de
Belgium | fr
Belgium | nl
Bulgaria | bg
Croatia | hr
Czech Republic | cs
Denmark | da
Finland | fi
France | fr
Germany | de
Hungary | hu
Italy | it
Netherlands | nl
Norway | no
Poland | pl
Portugal | pt
Romania | ro
Russia | ru
Slovakia | sk
Spain | es
Sweden | sv
Switzerland | de
Switzerland | fr
United Kingdom | en
Global | en
Sandoz | en
Saudi Arabia | ar
Turkey | tr
language-selector-globe Sandoz
Choose Location
Americas Asia Pacific Europe International Middle East & Africa
Argentina | es
Australia | en
Austria | de
Belgium | fr
Belgium | nl
Brazil | pt
Bulgaria | bg
Canada | en
Canada | fr
Croatia | hr
Czech Republic | cs
Denmark | da
Finland | fi
France | fr
Germany | de
Hungary | hu
Italy | it
Japan | ja
Korea | ko
Mainland China | zh
Mexico | es
Netherlands | nl
Norway | no
Global | en
Sandoz | en
Poland | pl
Portugal | pt
Romania | ro
Russia | ru
Saudi Arabia | ar
Slovakia | sk
Spain | es
Sweden | sv
Switzerland | de
Switzerland | fr
Turkey | tr
United Kingdom | en
United States | en
    • About Sandoz 
      • Our Purpose and Ambition 
      • What We Do 
      • Innovation, Quality and Supply 
      • Corporate Responsibility 
        • Ethics, Risk and Compliance 
        • Sandoz external funding 
        • Malaria Initiative 
        • Novartis Access 
        • World Child Cancer 
      • Our History 
      • Investor Information 
      A girl with a flower About Sandoz
    • Products & Services 
      • Disease Areas 
        • Anti-Infectives 
        • Respiratory 
        • Endocrinology 
        • Immunology 
        • Oncology 
      • Biopharmaceuticals 
        • Value of Biosimilars 
        • Sandoz Biosimilar Portfolio 
        • Sandoz Biosimilar Pipeline 
        • About Biologics 
        • Science of Biosimilars 
        • Information for Patients 
      • Prescription Medicines 
      • Over-The-Counter Medicines 
      • Partnerships and Collaborations 
        • Biotech Cooperations 
        • Business to Business (B2B) 
      00181_300dpi_RGB Products & Services
    • People & Culture 
      • Board of Directors 
      • Sandoz Leadership 
        • Richard Saynor 
        • Francisco Ballester 
        • Martin Bischof 
        • Colin Bond 
        • Pierre Bourdage 
        • Valerie Chew 
        • Claire D'Abreu-Hayling 
        • Glenn A. Gerecke, PhD 
        • Rebecca Guntern 
        • Keren Haruvi 
        • Tripti Jha 
        • Steffen Kurzawa 
        • Ingrid Sollerer 
      • Diversity & Inclusion 
      • Associate Stories 
    • Investors & Media 
      • Sandoz spin-off 
      • Media Releases 
      • Media Library 
      • Media Contacts 
      • Novartis Annual Reporting Suite 
    • Careers 
      • Diversity & Inclusion 
      • Associate Stories 
      • Job Search 
      • Our Teams 
        • Sandoz Technology 
        • Sandoz People & Organization 
      • Personal Growth & Learning at Sandoz 
      • Flexible-Hybrid Working at Sandoz 
      • People & Culture 
      • Diversity & Inclusion 
      • Rewards & Recognition 
      Sandoz Careers Careers
    • News 
      • News Archive 
      • Media Releases 
      • Publications 
      • Stay Up-To-Date 
      A photo of people in a meeting hall News
    • Contacts 
    working at sandoz Home
Header
Partnerships and Collaborations

Partnerships and Collaborations

Previous Next
  1. Home
  2. Products & Services
  3. Partnerships and Collaborations

Partnerships and Collaborations

Business to Business (B2B)

Sandoz B2B is a global business unit providing third-party pharmaceutical companies with access to an extensive portfolio of active pharmaceutical ingredients (APIs) and finished dosage forms (FDFs).

Biotech Cooperations

Sandoz is a world leading manufacturer of biotechnological products. Our expertise stems from decades of experience in this complex field, particularly in the production of intermediates for third parties.

AddToAny buttons

ShareTweetShareWhatsappLinkedinEmail

Printable Links Block (Content)

  • Print
  • PDF

Sandoz Global

Key resources
  • Patients & Caregivers
  • Job seekers
  • Investors
  • Media
Recent updates
  • Sandoz spin-off
Explore
  • Contacts
  • Locations
  • Biosimilar Portfolio and Pipeline
Sandoz Companies
  • 1A Pharma
  • Hexal
  • Lek
Footer Bottom
© 2023 Sandoz International GmbH
  • Terms of Use
  • Privacy
  • About Cookies
  • Legal Notice
  • Social Media Community Guidelines
  • Cookie Settings
  • Site Map
  • Web Accessibility
Novartis Site Directory
This site is intended for a global audience